Halozyme Therapeutics
HALO
#2442
Rank
โ‚ฌ6.45 B
Marketcap
54,48ย โ‚ฌ
Share price
-0.98%
Change (1 day)
2.44%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2025 (TTM): โ‚ฌ0.40 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are โ‚ฌ1.39 Billion. a decrease over its 2024 earnings that were of โ‚ฌ0.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025 โ‚ฌ0.39 B-16.2%
2024 โ‚ฌ0.47 B59.94%
2023 โ‚ฌ0.29 B39.94%
2022 โ‚ฌ0.21 B0.16%
2021 โ‚ฌ0.21 B92.2%
2020 โ‚ฌ0.11 B-278.96%
2019 -โ‚ฌ61.64 Million-9.45%
2018 -โ‚ฌ68.08 Million-229.51%
2017 โ‚ฌ52.55 M-160.48%
2016 -โ‚ฌ86.9 Million216.03%
2015 -โ‚ฌ27.5 Million-52.86%
2014 -โ‚ฌ58.34 Million-18.09%
2013 -โ‚ฌ71.22 Million55.88%
2012 -โ‚ฌ45.69 Million169.94%
2011 -โ‚ฌ16.93 Million-63.44%
2010 -โ‚ฌ46.29 Million-7.19%
2009 -โ‚ฌ49.88 Million15.91%
2008 -โ‚ฌ43.03 Million83.89%
2007 -โ‚ฌ23.4 Million78.1%
2006 -โ‚ฌ13.14 Million16%
2005 -โ‚ฌ11.33 Million45.24%
2004 -โ‚ฌ7.8 Million682.42%
2003 -โ‚ฌ1 Million1659.12%
2002 -โ‚ฌ0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.62 B 7,086.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ8.69 B 2,083.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ21.95 B 5,411.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ6.56 B 1,549.11%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚ฌ0.44 Billion-208.17%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚ฌ26.26 M-93.41%๐Ÿ‡บ๐Ÿ‡ธ USA